Exchange: NASDAQ·Updated 07:09 AM EDT
PLUR logo

PLUR Pluri Inc

$0.925
$0.0049
(0.53%)
Pre-Market
Prev Close $0.9299
Mkt Cap$11.73M
Vol11.00

About PLUR

Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.
55

Bullish Sentiment

How do you feel about PLUR?

Bumbleclod
$PLUR fighting hard to stay above a dollar. Once that falls under this is going to shit the bed quickly...........
1

Advertisement|Remove ads.